Listen to ASX-listed Venture Minerals Managing Director Andrew Radonjic talk to Matt Birney on the Bulls N’ Bears Report about Venture’s extraordinarily long tin/tungsten drill hit that comes at a time when the price of tin per tonne is blitzing both copper and nickel.

Listen to ASX-listed Memphasys Executive Chair Alison Coutts talk to Matt Birney on the Bulls N’ Bears Report about Memphasys’ very first clinical order for its remarkable IVF treatment device.

Listen to ASX-listed Arovella Therapeutics Managing Director Dr Michael Baker talk to Matt Birney on the Bulls N’ Bears Report about Arovella’s amazing technology that can temporarily remove blood cells from the body and reprogram them to seek and destroy cancer cells before being reinserted.

Listen to ASX-listed Neometals Managing Director Chris Reed talk to Matt Birney on the Bulls N’ Bears Report about Neometals’ groundbreaking lithium processing technology… that it owns jointly with mega miner Mineral Resources.

Listen to ASX-listed Race Oncology Managing Director Phillip Lynch talk to Matt Birney on the Bulls N’ Bears Report about Race Oncology’s cancer-fighting biotechnology that has been trialling well and is about to be put to the test again.

Listen to Orthocell Managing Director Paul Anderson talk to Matt Birney on the Bulls N’ Bears Report about Orthocell’s latest clinical trial that showed amazing success on people suffering from torn ligaments.